Image-Guided Surgery of Endocrine Glands and Their Tumors using Near-Infrared Flu

使用近红外流感图像引导内分泌腺及其肿瘤手术

基本信息

  • 批准号:
    8117244
  • 负责人:
  • 金额:
    $ 48.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Endocrine tumors, such as insulinoma, are rare but notoriously difficult to treat surgically due to their small size and poor contrast using white light. Endocrine tumors, such as ovarian cancer, are common but equally difficult to treat surgically, with improved survival dependent on complete cytoreduction. Similarly, normal endocrine tissues, such as the thyroid gland and adrenal gland, can often be difficult to locate during surgery due to adhesions and overlying fascia. Our hypothesis is that near-infrared (NIR) fluorophores targeted to endocrine glands and their tumors will provide surgeons with sensitive, specific, and real-time image- guidance after a single, pre-operative, intravenous injection. When used with an appropriate intraoperative imaging system, NIR fluorescent light from 700 to 900 nm can provide surgeons with real-time localization of normal and diseased tissue, without changing the look of the surgical field. As part of a previously funded Bioengineering Research Partnership (BRP) grant, we have developed the FLARE" (Fluorescence-Assisted Resection and Exploration) image-guided surgery system. FLARE provides real-time imaging of surgical anatomy (i.e., color video) simultaneously with two independent channels of NIR fluorescent light (700 nm and 800 nm emission). One NIR channel is typically reserved for the tissue to be resected (e.g., tumor) while the other is reserved for tissue that needs to be avoided (e.g., nerves, blood vessels, normal glands, etc.). FLARE has already been translated to the clinic where it is being used in breast cancer sentinel lymph node (SLN) mapping, lung cancer SLN mapping, and plastic surgery. The resection of endocrine gland tumors (e.g., insulinoma and ovarian cancer) and the avoidance of normal endocrine tissue (e.g., thyroid and adrenal glands) represent a significant unmet clinical need, with no available contrast agents. In collaboration with the Henary/Strekowski/Patonay laboratory at Georgia State University, recognized leaders in the field of fluorophore chemistry, we have developed novel NIR fluorophores tailored to endocrine imaging (endocrine-specific NIR fluorophores; ESNFs). Sharing structural and chemical similarities with naturally occurring hormones and drugs, ESNFs provide high contrast for image-guided surgery after a single intravenous injection into mice, rats, and pigs. The specific aims of this grant are focused on the synthesis of three new chemical classes of ESNFs, scale-up from analytical to preparative production, and optimization of their optical and chemical properties. Completion of these aims will lay the foundation for future clinical testing of ESNFs during image-guided surgery. PUBLIC HEALTH RELEVANCE: Invisible near-infrared fluorescent light can provide sensitive and specific guidance during surgery, but only if optimal contrast agents are available. Endocrine tissues and their tumors are particularly difficult to find during surgery, yet no endocrine-specific near-infrared fluorescent contrast agents presently exist. We have discovered endocrine-specific uptake by certain cyanine and basic aniline near- infrared fluorophores, and in this grant application, describe optimization of these agents and the development of three new families of near-infrared fluorophores for image-guided surgery.
描述(由申请人提供):内分泌肿瘤,如胰岛素瘤,是罕见的,但由于其体积小,白光对比度差,手术治疗非常困难。内分泌肿瘤,如卵巢癌,很常见,但同样难以手术治疗,其生存率的提高依赖于完全的细胞减少。同样,正常的内分泌组织,如甲状腺和肾上腺,由于粘连和上覆筋膜,在手术中往往难以定位。我们的假设是,针对内分泌腺及其肿瘤的近红外(NIR)荧光团将在单次术前静脉注射后为外科医生提供敏感、特异和实时的图像引导。当与合适的术中成像系统配合使用时,700 - 900 nm的近红外荧光可以为外科医生提供正常和病变组织的实时定位,而不会改变手术视野的外观。作为先前资助的生物工程研究伙伴关系(BRP)拨款的一部分,我们开发了FLARE“(荧光辅助切除和探查)图像引导手术系统。FLARE通过两个独立的近红外荧光通道(700 nm和800 nm发射)同时提供手术解剖的实时成像(即彩色视频)。一个近红外通道通常用于待切除组织(如肿瘤),而另一个通道用于需要避开的组织(如神经、血管、正常腺体等)。FLARE已经被应用于临床,用于乳腺癌前哨淋巴结(SLN)定位、肺癌SLN定位和整形手术。切除内分泌腺肿瘤(如胰岛素瘤和卵巢癌)和避开正常内分泌组织(如甲状腺和肾上腺)是一个重要的未满足的临床需求,没有可用的对比剂。我们与佐治亚州立大学的Henary/Strekowski/Patonay实验室(荧光团化学领域公认的领导者)合作,开发了专门用于内分泌成像的新型近红外荧光团(内分泌特异性近红外荧光团;esnf)。esnf与自然产生的激素和药物具有结构和化学相似性,在小鼠、大鼠和猪的单次静脉注射后,为图像引导手术提供了高对比度。这笔拨款的具体目的是集中在三种新的化学类esfs的合成,从分析到制备生产的规模扩大,以及其光学和化学性质的优化。这些目标的完成将为图像引导手术中esnf的临床测试奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hak Soo Choi其他文献

Hak Soo Choi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hak Soo Choi', 18)}}的其他基金

Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy
用于铁过载治疗的长效、短效纳米螯合剂
  • 批准号:
    10585319
  • 财政年份:
    2023
  • 资助金额:
    $ 48.93万
  • 项目类别:
Nanochelation Therapies for Iron Overload Disorders
纳米螯合疗法治疗铁过载疾病
  • 批准号:
    10318332
  • 财政年份:
    2021
  • 资助金额:
    $ 48.93万
  • 项目类别:
Nanochelation Therapies for Iron Overload Disorders
纳米螯合疗法治疗铁过载疾病
  • 批准号:
    10437625
  • 财政年份:
    2021
  • 资助金额:
    $ 48.93万
  • 项目类别:
Image-Guided Drug Delivery and Treatment for GIST
图像引导胃肠道间质瘤的药物输送和治疗
  • 批准号:
    9792375
  • 财政年份:
    2018
  • 资助金额:
    $ 48.93万
  • 项目类别:
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
图像引导胰腺神经内分泌肿瘤的药物输送。
  • 批准号:
    9302133
  • 财政年份:
    2017
  • 资助金额:
    $ 48.93万
  • 项目类别:
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor
图像引导胰腺神经内分泌肿瘤给药
  • 批准号:
    10167387
  • 财政年份:
    2017
  • 资助金额:
    $ 48.93万
  • 项目类别:
Image-Guided Drug Delivery for Pancreatic Neuroendocrine Tumor.
图像引导胰腺神经内分泌肿瘤的药物输送。
  • 批准号:
    9566182
  • 财政年份:
    2017
  • 资助金额:
    $ 48.93万
  • 项目类别:
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
用于体内成像和图像引导手术的超低背景近红外荧光团
  • 批准号:
    8514598
  • 财政年份:
    2010
  • 资助金额:
    $ 48.93万
  • 项目类别:
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
用于体内成像和图像引导手术的超低背景近红外荧光团
  • 批准号:
    7937599
  • 财政年份:
    2010
  • 资助金额:
    $ 48.93万
  • 项目类别:
Ultra-Low Background NIR Fluorophores for In Vivo Imaging and Image-Guided Surger
用于体内成像和图像引导手术的超低背景近红外荧光团
  • 批准号:
    8112741
  • 财政年份:
    2010
  • 资助金额:
    $ 48.93万
  • 项目类别:

相似海外基金

The role of ZNRF3/Znrf3 exon2 deletion on zonation and maintenance of the adrenal cortex
ZNRF3/Znrf3 外显子 2 缺失对肾上腺皮质分区和维持的作用
  • 批准号:
    22K08680
  • 财政年份:
    2022
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of the role of proinsulin-positive bone marrow-derived cells appearing in the adrenal cortex
研究肾上腺皮质中出现的胰岛素原阳性骨髓来源细胞的作用
  • 批准号:
    21K07338
  • 财政年份:
    2021
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The contribution of capsular and subcapsular progenitor cells in homeostatic adrenal cortex self-renewal and zonal-specific remodelling.
被膜和被膜下祖细胞在稳态肾上腺皮质自我更新和区域特异性重塑中的贡献。
  • 批准号:
    BB/V007246/1
  • 财政年份:
    2021
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Research Grant
Elucidating and modelling complex postnatal steroid hormone changes in preterm infants: insights into the developing immature neonatal adrenal cortex
阐明和模拟早产儿复杂的产后类固醇激素变化:深入了解发育中的未成熟新生儿肾上腺皮质
  • 批准号:
    MR/V037757/1
  • 财政年份:
    2021
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Research Grant
Role of the BMP system and effect on blood pressure regulation in the adrenal cortex
BMP 系统的作用及其对肾上腺皮质血压调节的影响
  • 批准号:
    20K17512
  • 财政年份:
    2020
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanism establishing sex difference in adrenal cortex cell proliferation by sex hormones
阐明性激素在肾上腺皮质细胞增殖中建立性别差异的机制
  • 批准号:
    20K08863
  • 财政年份:
    2020
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of sexually dimorphic functions of adrenal cortex by sex chromosomes
性染色体对肾上腺皮质性二态性功能的调节
  • 批准号:
    20H03436
  • 财政年份:
    2020
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying a role of delta-5 steroids from adrenal cortex for development of adrenal medulla
确定肾上腺皮质 delta-5 类固醇对肾上腺髓质发育的作用
  • 批准号:
    25860764
  • 财政年份:
    2013
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The production mechanism and role of progesterone in female mouse adrenal cortex.
雌性小鼠肾上腺皮质孕酮的产生机制及其作用。
  • 批准号:
    22591015
  • 财政年份:
    2010
  • 资助金额:
    $ 48.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular regulation of adrenal cortex homeostasis and remodeling
肾上腺皮质稳态和重塑的分子调节
  • 批准号:
    7897654
  • 财政年份:
    2009
  • 资助金额:
    $ 48.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了